Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) shares edged up 0.1% to $23.98, as the company is expected to report a quarterly loss at $0.18 per share on revenue of $44.15 million. Share volume totaled 6.1 million, compared to an all-day average of 9.1 million
